25567526|t|Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
25567526|a|BACKGROUND: The beta-secretase, BACE1, cleaves APP to initiate generation of the beta-amyloid peptide, Abeta, that comprises amyloid plaques in Alzheimer's disease (AD). Reducing BACE1 activity is an attractive therapeutic approach to AD, but complete inhibition of BACE1 could have mechanism-based side-effects as BACE1-/- mice show deficits in axon guidance, myelination, memory, and other neurological processes. Since BACE1+/- mice appear normal there is interest in determining whether 50% reduction in BACE1 is potentially effective in preventing or treating AD. APP transgenic mice heterozygous for BACE1 have decreased Abeta but the extent of reduction varies greatly from study to study. Here we assess the effects of 50% BACE1 reduction on the widely used 5XFAD mouse model of AD. RESULTS: 50% BACE1 reduction reduces Abeta42, plaques, and BACE1-cleaved APP fragments in female, but not in male, 5XFAD/BACE1+/- mice. 5XFAD/BACE1+/+ females have higher levels of Abeta42 and steady-state transgenic APP than males, likely caused by an estrogen response element in the transgene Thy-1 promoter. We hypothesize that higher transgenic APP level in female 5XFAD mice causes BACE1 to no longer be in excess over APP so that 50% BACE1 reduction has a significant Abeta42 lowering effect. In contrast, the lower APP level in 5XFAD males allows BACE1 to be in excess over APP even at 50% BACE1 reduction, preventing lowering of Abeta42 in 5XFAD/BACE1+/- males. We also developed and validated a dot blot assay with an Abeta42-selective antibody as an accurate and cost-effective alternative to ELISA for measuring cerebral Abeta42 levels. CONCLUSIONS: 50% BACE1 reduction lowers Abeta42 in female 5XFAD mice only, potentially because BACE1 is not in excess over APP in 5XFAD females with higher transgene expression, while BACE1 is in excess over APP in 5XFAD males with lower transgene expression. Our results suggest that greater than 50% BACE1 inhibition might be necessary to significantly lower Abeta, given that BACE1 is likely to be in excess over APP in the human brain. Additionally, in experiments using the 5XFAD mouse model, or other Thy-1 promoter transgenic mice, equal numbers of male and female mice should be used, in order to avoid artifactual gender-related differences.
25567526	0	5	Abeta	Gene	11820
25567526	19	24	BACE1	Gene	23821
25567526	43	48	5XFAD	CellLine	CVCL:5U93
25567526	49	53	mice	Species	10090
25567526	127	132	BACE1	Gene	23821
25567526	198	203	Abeta	Gene	11820
25567526	220	235	amyloid plaques	Disease	MESH:D058225
25567526	239	258	Alzheimer's disease	Disease	MESH:D000544
25567526	260	262	AD	Disease	MESH:D000544
25567526	274	279	BACE1	Gene	23821
25567526	330	332	AD	Disease	MESH:D000544
25567526	361	366	BACE1	Gene	23821
25567526	410	415	BACE1	Gene	23821
25567526	419	423	mice	Species	10090
25567526	517	522	BACE1	Gene	23821
25567526	526	530	mice	Species	10090
25567526	603	608	BACE1	Gene	23821
25567526	660	662	AD	Disease	MESH:D000544
25567526	679	683	mice	Species	10090
25567526	701	706	BACE1	Gene	23821
25567526	722	727	Abeta	Gene	11820
25567526	826	831	BACE1	Gene	23821
25567526	861	866	5XFAD	CellLine	CVCL:5U93
25567526	867	872	mouse	Species	10090
25567526	882	884	AD	Disease	MESH:D000544
25567526	899	904	BACE1	Gene	23821
25567526	945	950	BACE1	Gene	23821
25567526	1001	1006	5XFAD	CellLine	CVCL:5U93
25567526	1007	1012	BACE1	Gene	23821
25567526	1016	1020	mice	Species	10090
25567526	1022	1027	5XFAD	CellLine	CVCL:5U93
25567526	1028	1033	BACE1	Gene	23821
25567526	1182	1187	Thy-1	Gene	21838
25567526	1256	1261	5XFAD	CellLine	CVCL:5U93
25567526	1262	1266	mice	Species	10090
25567526	1274	1279	BACE1	Gene	23821
25567526	1327	1332	BACE1	Gene	23821
25567526	1422	1427	5XFAD	CellLine	CVCL:5U93
25567526	1441	1446	BACE1	Gene	23821
25567526	1484	1489	BACE1	Gene	23821
25567526	1535	1540	5XFAD	CellLine	CVCL:5U93
25567526	1541	1546	BACE1	Gene	23821
25567526	1752	1757	BACE1	Gene	23821
25567526	1793	1798	5XFAD	CellLine	CVCL:5U93
25567526	1799	1803	mice	Species	10090
25567526	1830	1835	BACE1	Gene	23821
25567526	1865	1870	5XFAD	CellLine	CVCL:5U93
25567526	1919	1924	BACE1	Gene	23821
25567526	1950	1955	5XFAD	CellLine	CVCL:5U93
25567526	2037	2042	BACE1	Gene	23821
25567526	2096	2101	Abeta	Gene	11820
25567526	2114	2119	BACE1	Gene	23821
25567526	2162	2167	human	Species	9606
25567526	2214	2219	5XFAD	CellLine	CVCL:5U93
25567526	2220	2225	mouse	Species	10090
25567526	2242	2247	Thy-1	Gene	21838
25567526	2268	2272	mice	Species	10090
25567526	2307	2311	mice	Species	10090
25567526	Association	MESH:D000544	23821
25567526	Association	MESH:D000544	11820
25567526	Association	11820	23821

